Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum The Medipattern Corporation V.MKI

TSXV:MKI - Post Discussion

The Medipattern Corporation > info on this weekend past prresentation
View:
Post by rajualem on Oct 29, 2012 7:08pm

info on this weekend past prresentation

Does anyone know how the presentation went this weekend

 

The Medipattern Corporation ("Medipattern") (TSX VENTURE:MKI), congratulates authors Daniel Gurell, MD and Marc Prager, MD for their work comparing Visualize:Vascular™ to Magnetic Resonance Angiography (MRA). Their study shows that Visualize:Vascular's 3D luminal ultrasound visualization correlates well with MRA in a paper slated for presentation this coming weekend during the 2012 annual meeting of the Society of Radiologists in Ultrasound (SRU), which is a sub-committee of the American College of Radiology. The blinded study uses the results of ultrasound scans from 100 consecutive carotid arteries. Qualifying cases were further evaluated using MRA. Results were then compared between the two technologies. A correlation of 99%, p<.05 was found between the two imaging technologies. The results are statistically significant. Angiography is considered to be the gold standard in evaluating arterial integrity.

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities